Since the domestication of the urus, 10.000 years ago, mankind utilizes bovine milk for different purposes. Besides usage as a nutrient also the external application of milk on skin has a long tradition going back to at least the ancient Aegypt with Cleopatra VII as a great exponent. In order to test whether milk has impact on skin physiology, cultures of human skin fibroblasts were exposed to commercial bovine milk. Our data show significant induction of proliferation by milk (max. 2,3-fold, EC50: 2,5% milk) without toxic effects. Surprisingly, bovine milk was identified as strong inducer of collagen 1A1 synthesis at both, the protein (4-fold, EC50: 0,09% milk) and promoter level. Regarding the underlying molecular pathways, we show functional activation of STAT6 in a p44/42 and p38-dependent manner. More upstream, we identified IGF-1 and insulin as key factors responsible for milk-induced collagen synthesis. These findings show that bovine milk contains bioactive molecules that act on human skin cells. Therefore, it is tempting to test the herein introduced concept in treatment of atrophic skin conditions induced e.g. by UV light or corticosteroids.
Introduction
Domestication of the urus in Eurasia took place in the Pre-Pottery Neolithic. Besides the cultivation of land, cattle husbandry was mainly exploited for the production of meat and milk. In addition to fresh milk, cultural techniques created a plethora of milk-derived products such as cheeses and yoghurts serving the nutrition of man. Although, milk is generally associated with a positive image there is increasing evidence that enteral consumption of milk may be a trigger factor for some diseases. What sure is, milk, and particularly colostrums, supports health in many neonates including humans. Particularly, the supply with milk-derived immunoglobulins is known to reduce infections in newborns [1] . Excluding the period of breastfeeding, milk, and milk-derived products, consumed by humans are mainly from bovine source. Now, there is debate about the relevance of bioactive factors present in bovine milk for human health [2] . In regard to human skin large clinical trials have shown a correlation between milk consumption and acne vulgaris [3, 4] . Corroboratively, recent studies found that high milk intake is associated with other health disorders. In this respect an elevated mortality and, most surprisingly, also a higher facture incidence, was found [5] . Moreover, diet with milk and dairy products is suspected to contribute to male reproductive disorders because of the levels of estrogen therein [6] . On the other side there is evidence that, at least factors contained in milk, have beneficial effects on human health. For example conjugated linoleic acid (CLA), a transfatty acid, offers anticarcinogenic, antiatherogenic and antidiabetogenic properties [7] [8] [9] .
Besides enteral use, external application of milk and milk components look back on a history of several thousand years. Tradition has it that Cleopatra VII, Elizabeth I of England, Elisabeth ("Sisi") of Bavaria and others have bathed in milk for beautifying benefits. And still today cosmetic products, containing milk-derived ingredients, are marketed for skin care. In addition to this, polar lipids from bovine milk have been shown to penetrate the intact skin inducing hair cycle progression in a mouse model [10] . Moreover, expressed maternal milk seems to alleviate nipple pain in breastfeeding women [11] . Interestingly, also clinical conditions such as papillomas benefit from a topical treatment with a α-lactalbumin preparation extracted from human milk as shown by a clinical trial [12] .
The aforementioned examples inspired the present study to test whether bovine milk has impact on the physiology of dermal fibroblasts. Most interestingly, we found upregulation of proliferation and collagen synthesis by bovine milk. These results provide a scientific rational for treatment of atrophic skin with topical preparations containing milk or milk-derived factors.
Materials and Methods

Ethics Statement
This study was conducted according to the Declaration of Helsinki Principles and in agreement with the Local Ethic Commission of the faculty of Medicine of the Johann Wolfgang Goethe University (Frankfurt am Main, Germany). The Local Ethic Commission waived the need for consent.
Reagents and antibodies
Fresh bovine milk (Weihenstephan, 3.5% fat) was aliquot and stored until use at -20°C. Insulin, IGF-1 and testosterone were purchased from Sigma-Aldrich (Taufkirchen, Germany), TGFβ1 was from R&D Systems (Wiesbaden, Germany). The following neutralizing antibodies were used: anti-IGF-1 (#5119-100, BioVision, Heidelberg, Germany), anti-TGFβ1,2,3 (MAB1835, R&D Systems) and anti-insulin receptor (MA-20, Novus Biologicals, Cambridge, UK). The MEK1 inhibitor PD98059 was from Cell Signaling (Frankfurt, Germany). PI3K inhibitor LY-294002, EGF receptor tyrosine kinase inhibitor AG1478 and p38 inhibitor SB203580 were purchased from Calbiochem-Novabiochem (Darmstadt, Germany). Leflunomide to inhibit signal transducers and activators of transcription 6 (STAT6) signalling [13] was from Sigma-Aldrich. For Western blotting, activation of signalling molecules was detected with primary phosphospecific antibodies against PKB/Akt (Ser473/Thr308), p44/42 (Thr202/Tyr204), p38 (Thr180/ Tyr182) (all from Cell Signaling Technology) and pSTAT6 (Tyr641) (from Santa Cruz Biotechnology, Heidelberg, Germany). Equal loading was controlled with an antibody against total PKB/Akt (Cell Signaling Technology) and β-actin (Sigma-Aldrich).
Cell culture
Normal human skin fibroblasts were isolated either from preputia (or from abdominal skin for control experiments, S1 Fig) . If not otherwise indicated experiments were performed with preputial fibroblasts. Cells were propagated in RPMI 1640 medium (Biochrom, Berlin, Germany) with 10% FCS (PAA, Cölbe, Germany) and 1% penicillin-streptomycin solution (Biochrom KG, Berlin, Germany) at 37°C in a 5% CO 2 -atmosphere. The medium was renewed twice a week. All experiments were done in agreement with the local ethics commission.
DNA synthesis
Cells were cultivated in microwell plates at a density of 2x10 4 cells/0.33 cm 2 . Cells were exposed for 24 hours to bovine milk at the indicated concentrations. For the last 24 hours cells were pulsed with 5-bromo-2 0 -deoxyuridine (BrdU). Subsequently, the incorporation rate of BrdU was determined using a commercial enzyme-linked immunosorbent assay kit (Roche, Mannheim, Germany). Briefly, cells were fixed and immune complexes were formed using peroxidase-coupled BrdU-antibodies. A colorimetric reaction with tetramethylbenzidine as a substrate gives rise of a reaction product measured at 450 nm in a scanning multiwell spectrophotometer (ELISA reader, MR 5000, Dynatech, Guernsey, UK).
Membrane integrity
Cell lysis was quantified using the cytotoxicity detection kit (Roche), which is based on the release of lactate dehydrogenase (LDH) from damaged cells. Briefly, cells were seeded out in microwell plates at a density of 2x10 4 cells/0.33 cm 2 and treated with bovine milk at the indicated concentrations for 24 hours. Consecutively, the cell-free supernatants were incubated with NAD+, which becomes reduced by LDH to NADH/H+. In a second step NADH/H + reduces a yellow tetrazolium salt to a red-coloured formazan salt. The amount of red colour is proportional to the number of lysed cells. For quantitation, the absorbance of the reaction product was measured at 490 nm using a multiwell spectrophotometer.
Determination of collagen 1A1 synthesis
Collagen synthesis was determined by measuring the concentration of P1NP in the cell medium as described [14, 15] . Briefly, normal human skin fibroblasts were cultured for 48 hours with the indicated compounds. Then, cell-free supernatants were collected and analyzed for P1NP according to the manufacturer's instructions (P1NP-Elecsys assay, Roche Pharmaceuticals, Grenzach-Wyhlen, Germany). An antigen/antibody complex is formed by addition of biotin-labeled anti-P1NP and Ru(bpy) 3 2+ -labeled anti-P1NP. Consecutively, the antigen/ antibody complex becomes bound to streptavidin-coated magnetic micro-particles added to the sample. The micro-particles were enriched by magnetic separation. After several washes the chemiluminescence is measured with a photomultiplier (Elecsys, Roche).
Collagen 1A1 promoter transactivation assay
The human collagen 1A1 promoter constructs spanning -2300/+18 and -205/+18, respectively, linked to a luciferase reporter gene in pGL3 basic (Promega, Mannheim, Germany) were a kind gift from Annett Skupin [16] . Constructs were transfected into subconfluently grown human skin fibroblasts by lipofection (Lipofectamin reagent 2000, Invitrogen). In order to standardize transfection efficacy cells were co-transfected with a humanized Renilla luciferase vector (phRL, Promega). Cells were treated with 10% milk or 10 ng/ml TGFβ1 for 48 hours. Finally, cells were lysed and luciferase activities of both luciferases were detected separately, using the Dual-Luciferase Reporter Assay System (Promega) and a luminometer (Berthold, Bad Wildbad, Germany).
Immunoblotting
For detection of activated PKB/Akt, p44/42, p38, STAT6 and total PKB/Akt and β-actin cells were lysed in 100 μl SDS sample buffer (62.5 mM Tris-HCl [pH 6.8], 2% SDS,10% glycerol, 50 mM DTT, 0.1% bromphenol blue), sonicated, boiled for 5 min, and separated on SDSpolyacrylamide gels. Consecutively, proteins were immunoblotted to a PVDF membrane. The membrane was blocked in blocking buffer (TBS [pH 7.6], 0.1% Tween-20, 5% nonfat dry milk) for at least 3 hours at 4°C followed by incubation with the primary antibody in TBS (pH 7.6), 0.05% Tween-20, and 5% BSA. The bound primary antibodies were detected using anti-mouse IgG-horseradish peroxidase conjugate and visualized with the LumiGLO detection system (Cell Signalling).
Presentation of data and statistical analysis
All data are presented as mean values ± standard deviation. Statistical significance of the data was calculated by the ANOVA-test (BIAS, Frankfurt, Germany). Each set of data was related to the referring untreated controls. To estimate effects of inhibitors or blocking antibodies data were related to positive controls treated with bovine milk and mouse IgG (mIgG). Differences were considered significant at p < 0.05 indicated by an asterisk.
Results
Bovine milk induces proliferation
Normal human fibroblasts were exposed to bovine milk to test the impact on basal cell parameters such as proliferation and morphology. It was found that substitution of FCS by bovine milk leads to a concentration dependent increase of proliferation compared to cells held in the absence of FCS (Fig 1a) . Already at a concentration of 0,025% of bovine milk a significant growth promoting effect was measured. A maximum induction of 2,3-fold was observed in the presence of 30% bovine milk. The calculated EC50 value was reached at 2,5% milk. Additional experiments comparing preputial and abdominal fibroblasts showed similar results (S1 Fig) .
The milk-induced effect was compared to regular supplementation with FCS (Fig 1b) . The figure shows a modest growth-promoting effect at 1% FCS reaching maximum induction of 1,9-fold at 50% FCS with an EC50 at 3% FCS. In order to regard toxic effects LDH levels were measured (Fig 1c) . Pretrials demonstrate significant amounts of LDH in medium containing milk or FCS (data not shown). These values become subtracted from supernatants derived from cell cultures. The data shown indicate no cytotoxic effect of either milk or FCS on fibroblasts. Corrobatively, experiments measuring cytoplasmic histone-associated DNA fragments as markers for apoptosis showed no upregulation by milk (data not shown). Moreover, the effect of bovine milk on cell morphology was tested (Fig 2) . Replacement of FCS by milk induces a stretched, more spindle-like, cell morphology. In addition, the cells become uniformly orientated like fish in a swarm.
Bovine milk induces collagen 1A1
The collagen1A1 synthesis was quantified by determining the amount of pro-collagen type 1 N-terminal pro-peptide (P1NP). Supplementation of the basal medium with bovine milk showed a concentration dependent increase of P1NP to about 4-fold after 48 hours with an EC50 at 0,09% bovine milk (Fig 3a) . In all experiments shown in this paper the induction of P1NP by bovine milk was significant, but varied, as expected for biological systems. The body areas where cells were obtained and the donor age may be important parameters for the degree of P1NP induction by bovine milk. Of note, experiments performed with increasing FCS-concentrations showed no significant impact on collagen synthesis (Fig 3b) In order to corroborate the effects of bovine milk on collagen synthesis, promoter transactivation assays were performed (Fig 3c) . As positive control served TGFβ1, a well known inductor of collagen synthesis [17, 18] . Our data show significant promoter transactivation for both, TGFβ1 and 10% bovine milk, in a promoter construct spanning from -2300bp to + 18bp. Using a deletion mutant devoid of STAT6 binding motifs (#1-5,6,7) spanning a sequence from -205bp to +18bp [16] TGFβ1 still induces significant promoter transactivation whereas 10% bovine milk failed. These results support findings describing the relevance of STAT6 in collagen promoter transactivation [16] .
Activation of signaling molecules by bovine milk
In order to identify signaling pathways involved in collagen induction by bovine milk fibroblasts were treated with 10% bovine milk for 10, 30, 60 minutes and 4 hours, then, harvested and subjected to Western blot analysis (Fig 4) . Using phosphospecific antibodies against key factors in cell signaling revealed a fast and strong activation of PKB/Akt, p44/42 and p38 within 10 minutes. This activation was similar for FCS. Looking at PKB/Akt the milk-induced activation decreased faster with time than in the case of FCS. Of note, 4 hours after adding FCS a significant activation is still present. The phosphorylation of p44/42 by bovine milk and FCS was similar, lasting for at least 60 minutes. Phosphorylation of p38 after 30 minutes was more distinct for FCS than for bovine milk. Longer incubations showed only marginal signals for both compounds.
Soluble factors in bovine milk induce collagen synthesis
One of the most likely candidate factors within milk responsible for milk-induced collagen synthesis is TGFβ1 which was shown to increase collagen synthesis [17, 18] . The effect of recombinant TGFβ1 on P1NP is given in Fig 5a featuring a concentration dependent increase. In order to eliminate TGFβ1 from milk the neutralizing antibody MAB1835, specific for TGF1, 2 and 3 subsets, was used (Fig 5b) . Of note, only at high concentrations (>10 μg/ml) a slight but significant suppression of milk-induced P1NP synthesis was observed. However, at 20 μg/ml MAB1835 the suppression was only 20% compared to the control indicating that TGFβ1 is not the main component in milk responsible for collagen synthesis. In order to test other candidate molecules present in milk cells were stimulated with IGF-1, insulin and testosterone (Fig 6a) . For IGF-1 and insulin a concentration dependent increase of P1NP synthesis was found. However, both compounds failed to reach the level measured with bovine milk. Moreover, testosterone showed no stimulatory effect on collagen synthesis. To further substantiate the role of IGF-1 and insulin, milk was supplemented with neutralizing antibody against IGF-1 (Fig  6b) and the insulin receptor (Fig 6c) . The milk-inducing effect on collagen synthesis was significantly reduced in the presence of anti-IGF-1 and MA-20, respectively. This indicates that both, IGF-1 and particularly insulin, play a major role in collagen synthesis induced my bovine milk.
Activation of STAT6 by bovine milk mediates collagen synthesis
Data derived from promoter transactivation assays suggest a role of STAT6 in the collagen promoting effect of bovine milk (Fig 3c) . This observation was substantiated by showing that the addition of bovine milk led to a concentration and time dependent induction of p-STAT6 phosphorylation (Fig 7a) . Using leflunomide, an inhibitor of p-STAT6 [13] , reverted the milkinduced p-STAT6 phosphorylation corroborating the aforementioned effect of this agent (Fig  7a) . In a pretrial we tested that leflunomide has no cytotoxic impact at concentrations used (S2 Fig). Corroborating the effect of p-STAT6 in our model we show a significant inhibition of milk-induced collagen synthesis in the presence of leflunomide (Fig 7b) . In order to learn more about upstream signaling we performed experiments using specific kinase inhibitors. These experiments feature significant fainter bands of p-STAT6 in cells treated with PD98059, and particularly with SB203580 (Fig 7c) . These data suggest a contribution of the MEK1 and p38 pathway. Finally, it was investigated if IGF-1 and insulin, identified as collagen inductors in bovine milk, were capable to induce STAT6 phosphorylation. As shown in Fig 7d  IGF-1 induces phosphorylation in a concentration dependent manner, insulin shows no such effect. 
Discussion
Milk is a cocktail of bioactive compounds. Besides lactose, the distinctive milk disaccharide, it contains considerable amounts of amino acids, minerals and vitamins [19] , a plethora of about 400 different fatty acids [20] and also large amounts of microRNAs [21, 22] . Moreover, endocrine factors such as steroid and peptide hormones are present. Additionally, bovine milk contains various growth factors with TGFβ-α/β and IGF-1 as key factors [23] . All these factors are considered to regulate the neonatal body function. Interestingly, there is evidence that milk consumption increases also IGF-1 serum levels [24, 25] by possibly a direct transfer from the gastrointestinal tract into systemic circulation [26] . Therefore, it could be speculated that some milk derived factors may take effect also systemically. By topical application, however, these factors can directly act on skin cells, particularly under conditions with impaired skin barrier.
Our results demonstrate that bovine milk modulates basic physiologic factors of skin fibroblasts. In particular, we observed an induction of proliferation accompanied with morphological changes. Specifically, cells become unidirectionally stretched, which fits well to the growthínducing effect, as cell stretch was identified as potent inductor of proliferation and proliferation-associated kinases [27, 28] . However, the key finding of this paper describes the strong induction of collagen 1A1 synthesis in response to bovine milk. In order to identify factors within milk responsible for this effect, TGFβ1 seemed to be the most likely candidate molecule, known to induce collagen synthesis [29] . Of note, medium supplemented with TGFβ1 showed only meager induction of P1NP compared with bovine milk. Likewise, neutralization of TGFβ1 within milk resulted only in a modest reduction of milk-induced collagen synthesis. This finding indicates that TGFβ1 plays at least only a minor part in collagen induction. Next, IGF-1, another collagen-inducing growth factor [30] , was tested. In contrast to the aforementioned experiments with TGFβ1, neutralization of IGF-1 showed a strong inhibition of the collagen promoting effect of bovine milk underlining the significance of this bioactive factor in this context. The stimulatory effect of IGF-1 can be modulated by carrier proteins belonging to the IGF binding protein (IGFBP) family which are present in bovine milk [23] and also known to be produced by fibroblasts themselves [31] . Moreover, we investigated the role of insulin on collagen synthesis. Similar to IGF-1, insulin given to fibroblasts increased collagen synthesis in fibroblasts which is in concert with previous findings [32] [33] [34] . Neutralization of insulin within milk by an antibody directed against the insulin receptor (MA-20) caused the strongest suppression of collagen synthesis followed by IGF-1 and TGFβ1, having only a weak effect. However, insulin given to the cells does not activate STAT6 indicating that also other signaling molecules are involved in the regulation of collagen synthesis. Promotor analysis of the Col1A1 gene showed also binding motifs for other transcription factors such as AP2, NF1 and SP1 [1] which may contribute to the observed insulin effect. Besides growth factors bovine milk contains considerable amounts of sex steroid hormones including progesterone and its metabolite testosterone [35] . Others have shown that some anabolic steroid hormones stimulated collagen synthesis [36] . Therefore, the effect of testosterone, present in a concentration ranging between 50 and 150pg/ml in bovine milk [37] , was tested. Our data show no regulation of collagen synthesis by testosterone.
Regarding signal transduction we found STAT6 being an important factor. In particular we provide evidence that collagen promoter transactivation in response to milk is sensitive to the presence of STAT6 binding sites. A similar finding was reported for IL4 signalling [16] . Moreover, this finding was substantiated by showing that milk phosphorylates STAT6. Vice versa, Leflunomide, a STAT6 inhibitor, diminished milk-induced collagen synthesis. In parallel a transient activation of PKB/Akt, p44/42 and p38 by bovine milk was found. Specific inhibitors targeting the p44/42 and p38 pathway inhibited milk-induced STAT6 phosphorylation, whereas PKB/Akt does not seem to be involved. Although, STAT6 is prototypically phosphorylated in a IL-4 and IL-13 dependent manner [38] our result show also activation upon IGF-1 stimulation which is concert with recent findings [39] . Assuming that STAT6 is a key player in adaptive immunity [40, 41] , it could be speculated that exposure of skin to milk-derived factors such as IGF-1 may have also an effect in this context.
In sum, our data show that bovine milk which is traditionally used for skin care offers significant effects on skin fibroblasts. Particularly, the strong induction of proliferation and collagen synthesis makes this body fluid an interesting subject for clinical tests. It could be speculated from our findings that clinical conditions featuring a downregulated fibroblast metabolism, which prototypically occurs in UV-aged skin and after long-term corticosteroid treatment, may benefit from topical agents containing milk-derived factors.
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